FIRST CLINICAL RESULTS OF ADCT-402, A NOVEL PYRROLOBENZODIAZEPINE-BASED ANTIBODY DRUG CONJUGATE (ADC), IN RELAPSED/REFRACTORY B-CELL LINEAGE NHL
Kahl, B., Hamadani, M., Caimi, P.F., Reid, E.G., Havenith, K., He, S., Feingold, J.M., O'Connor, O.A.Volume:
35
Language:
english
Journal:
Hematological Oncology
DOI:
10.1002/hon.2437_33
Date:
June, 2017
File:
PDF, 169 KB
english, 2017